5009611000001102: Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)
\UK product\Virtual medicinal product\Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 500 milligram/1 vial powder for conventional release solution for injection\Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)
\UK product\Virtual therapeutic moiety\Cyclophosphamide\Product containing only cyclophosphamide in parenteral dose form (medicinal product form)\Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 500 milligram/1 vial powder for conventional release solution for injection\Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)
\UK product\Virtual therapeutic moiety\Cyclophosphamide\Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 500 milligram/1 vial powder for conventional release solution for injection\Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)
\UK product\Trade family\Endoxana\Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing alkylating agent\Medicinal product containing nitrogen mustard derivative and acting as antineoplastic agent (product)\Product containing cyclophosphamide\Cyclophosphamide\Product containing only cyclophosphamide in parenteral dose form (medicinal product form)\Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 500 milligram/1 vial powder for conventional release solution for injection\Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing alkylating agent\Medicinal product containing nitrogen mustard derivative and acting as antineoplastic agent (product)\Product containing cyclophosphamide\Cyclophosphamide\Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 500 milligram/1 vial powder for conventional release solution for injection\Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing alkylating agent\Medicinal product containing nitrogen mustard derivative and acting as antineoplastic agent (product)\Product containing cyclophosphamide\Product containing cyclophosphamide in parenteral dose form (medicinal product form)\Product containing only cyclophosphamide in parenteral dose form (medicinal product form)\Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 500 milligram/1 vial powder for conventional release solution for injection\Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing nitrogen mustard derivative and acting as antineoplastic agent (product)\Product containing cyclophosphamide\Cyclophosphamide\Product containing only cyclophosphamide in parenteral dose form (medicinal product form)\Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 500 milligram/1 vial powder for conventional release solution for injection\Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing nitrogen mustard derivative and acting as antineoplastic agent (product)\Product containing cyclophosphamide\Cyclophosphamide\Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 500 milligram/1 vial powder for conventional release solution for injection\Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing nitrogen mustard derivative and acting as antineoplastic agent (product)\Product containing cyclophosphamide\Product containing cyclophosphamide in parenteral dose form (medicinal product form)\Product containing only cyclophosphamide in parenteral dose form (medicinal product form)\Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 500 milligram/1 vial powder for conventional release solution for injection\Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)
\Medicinal product\Product manufactured as parenteral dose form\Product containing cyclophosphamide in parenteral dose form (medicinal product form)\Product containing only cyclophosphamide in parenteral dose form (medicinal product form)\Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 500 milligram/1 vial powder for conventional release solution for injection\Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

18548101000001117 Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

18548201000001112 Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)	Is a	Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 500 milligram/1 vial powder for conventional release solution for injection	true	Inferred relationship	Existential restriction modifier
Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)	Has active ingredient	Cyclophosphamide	false	Inferred relationship	Existential restriction modifier
Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)	Has active ingredient	Cyclophosphamide monohydrate	false	Inferred relationship	Existential restriction modifier
Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)	Has manufactured dose form	Powder for conventional release solution for injection	false	Inferred relationship	Existential restriction modifier
Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)	Is a	Endoxana	true	Inferred relationship	Existential restriction modifier
Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Cyclophosphamide	true	Inferred relationship	Existential restriction modifier
Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)	Has specific active ingredient	Cyclophosphamide monohydrate	false	Inferred relationship	Existential restriction modifier
Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)	Has dispensed dose form	Powder for conventional release solution for injection	true	Inferred relationship	Existential restriction modifier
Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)	Has manufactured dose form	Injection	false	Inferred relationship	Existential restriction modifier
Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)	Has specific active ingredient	Cyclophosphamide monohydrate	true	Inferred relationship	Existential restriction modifier
Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)	Has basis of strength substance	Cyclophosphamide	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd) 1 vial	Is pack of	False	Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)	Inferred relationship	Existential restriction modifier
Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd) 1 vial	Has AMP	True	Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
18548101000001117	Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
18548201000001112	Endoxana 500mg powder for solution for injection vials (Baxter Healthcare Ltd)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module